ARK reports 2.73M SRTA shares (3.16%)

Strata Critical Medical, Inc. reports a Schedule 13G/A amendment showing ARK Investment Management LLC and Catherine D. Wood beneficially own 2,730,855 shares of Common Stock, equal to 3.16% of the class.

Rhea-AI Filing Summary

Strata Critical Medical, Inc. reports a Schedule 13G/A amendment showing ARK Investment Management LLC and Catherine D. Wood beneficially own 2,730,855 shares of Common Stock, equal to 3.16% of the class. The filing lists voting and dispositive power allocations between ARK and Ms. Wood.

Insights

Institutional Ownership Analyst

ARK and Catherine D. Wood hold 2.73M SRTA shares, a 3.16% stake.

ARK Investment Management LLC is reported with sole voting and dispositive power over 2,730,855 shares, while Catherine D. Wood is shown with shared voting and dispositive power for the same amount. The filing is an amended Schedule 13G/A reflecting beneficial ownership.

These disclosures document ownership proportions; any market impact depends on future transactions or additional disclosures in subsequent filings.

Corporate Compliance Officer

Disclosure follows Schedule 13G/A requirements and allocates powers between filer entities.

The amendment lists ARK and Catherine D. Wood as filers, provides the issuer address, CUSIP 092667104, and states the holding equals 3.16% of common stock. It also includes signature and dates of amendment.

Filing indicates passive/beneficial ownership reporting; subsequent Form 13D or Form 4 would be required for materially different disclosure obligations.

Key Figures

Form type: Schedule 13G/A Shares beneficially owned: 2,730,855 shares Percent of class: 3.16% +1 more

4 metrics

Form type Schedule 13G/A Amendment filed for Strata Critical Medical, Inc.

Shares beneficially owned 2,730,855 shares Reported by ARK Investment Management LLC and Catherine D. Wood

Percent of class 3.16% Percent of Common Stock as stated in filing

CUSIP 092667104 Identifier listed for Common Stock

Key Terms

Schedule 13G/A, beneficially owned, sole/disposed power

3 terms

Schedule 13G/A regulatory

"Amendment No. 7 ) Strata Critical Medical, Inc."

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

beneficially owned financial

"Item 4. | Ownership (a) | Amount beneficially owned: ARK and Catherine D. Wood: 2,730,855"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole/disposed power regulatory

"Sole power to dispose or to direct the disposition of: (i) ARK: 2,730,855"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many SRTA shares does ARK report holding?

ARK and Catherine D. Wood report beneficial ownership of 2,730,855 shares. The Schedule 13G/A amendment states this equals 3.16% of Strata Critical Medical's common stock and lists voting and dispositive power allocations.

What voting and dispositive powers are disclosed in the SRTA filing?

The filing shows ARK holds sole voting and sole dispositive power over 2,730,855 shares. Catherine D. Wood is shown with shared voting and shared dispositive power for the same 2,730,855-share position.

Is this a Schedule 13G or 13D filing for SRTA?

This document is an amended Schedule 13G/A filing. It reports beneficial ownership consistent with passive investor reporting rather than an active 13D acquisition disclosure.

What CUSIP is associated with the reported SRTA shares?

The filing lists the CUSIP as 092667104. That identifier is included on the Schedule 13G/A cover information alongside the issuer name and class of securities (Common Stock).

When was the Schedule 13G/A amendment signed for SRTA?

The Schedule 13G/A amendment is signed and dated 07/08/2026 by Kellen Carter and Catherine D. Wood. Signatures appear at the end of the filing excerpt provided.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/08/2026 - 06:17 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 7)

Strata Critical Medical, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

092667104

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 092667104

1

Names of Reporting Persons

ARK Investment Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,730,855.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,730,855.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,730,855.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.16 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP Number(s): 092667104

1

Names of Reporting Persons

Catherine D. Wood

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,730,855.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,730,855.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,730,855.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.16 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Strata Critical Medical, Inc.
(b)	Address of issuer's principal executive offices: 666 Third Avenue, 25th Floor, New York, NY, 10017
Item 2.
(a)	Name of person filing: (i) ARK Investment Management LLC ("ARK") (ii) Catherine D. Wood
(b)	Address or principal business office or, if none, residence: ARK and Catherine D. Wood: 200 Central Avenue, St. Petersburg, FL 33701
(c)	Citizenship: (i) ARK: Delaware (ii) Catherine D. Wood: United States
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 092667104
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: ARK and Catherine D. Wood: 2,730,855
(b)	Percent of class: ARK and Catherine D. Wood: 3.16
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: (i) ARK: 2,730,855 (ii) Catherine D. Wood: 0
	(ii) Shared power to vote or to direct the vote: (i) ARK: (ii) Catherine D. Wood: 2,730,855
	(iii) Sole power to dispose or to direct the disposition of: (i) ARK: 2,730,855 (ii) Catherine D. Wood: 0
	(iv) Shared power to dispose or to direct the disposition of: (i) ARK: 0 (ii) Catherine D. Wood: 2,730,855
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

ARK Investment Management LLC

Signature:	/s/ Kellen Carter
Name/Title:	Kellen Carter, Chief Compliance Officer
Date:	07/08/2026

Catherine D. Wood

Signature:	/s/ Catherine D. Wood
Name/Title:	Catherine D. Wood, Chief Executive Officer, Chief Investment Officer
Date:	07/08/2026